CAPLIN POINT LABORATORIES Trademark
Trademark Overview
On Thursday, August 24, 2023, a trademark application was filed for CAPLIN POINT LABORATORIES with the United States Patent and Trademark Office. The USPTO has given the CAPLIN POINT LABORATORIES trademark a serial number of 98148403. The federal status of this trademark filing is FINAL REFUSAL - MAILED as of Sunday, July 28, 2024. This trademark is owned by Caplin Point Laboratories Limited. The CAPLIN POINT LABORATORIES trademark is filed in the Pharmaceutical Products, Advertising and Business and Retail Services categories with the following description:
Pharmaceutical and Medicinal Preparations
Providing business intelligence services in the fields of medical devices, pharmaceuticals and the life sciences
General Information
| Serial Number | 98148403 |
| Word Mark | CAPLIN POINT LABORATORIES |
| Filing Date | Thursday, August 24, 2023 |
| Status | 645 - FINAL REFUSAL - MAILED |
| Status Date | Sunday, July 28, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Description of Mark | The mark consists of the wording "CAPLIN POINT" in black above the term "LABORATORIES," also in black," to the left of which is a red circular design bisected in the middle by a white vertical line and with a stylized white and red syringe placed horizontally across the circle and vertical line pointing toward the right and a white hook shape in the bottom right of the circle |
| Goods and Services | Pharmaceutical and Medicinal Preparations |
| Indication of Colors claimed | The colors black, red, and white are claimed as a feature of the mark. |
| Goods and Services | Providing business intelligence services in the fields of medical devices, pharmaceuticals and the life sciences |
| NOT AVAILABLE | Labortories |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Sunday, September 24, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | Wednesday, May 4, 2016 |
| First Use In Commerce Date | Wednesday, May 4, 2016 |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Sunday, September 24, 2023 |
| Primary Code | 035 |
| First Use Anywhere Date | Wednesday, May 4, 2016 |
| First Use In Commerce Date | Wednesday, May 4, 2016 |
Trademark Owner History
| Party Name | Caplin Point Laboratories Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Chennai 600096
IN |
Trademark Events
| Event Date | Event Description |
| Sunday, September 24, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, August 28, 2023 | NEW APPLICATION ENTERED |
| Wednesday, December 6, 2023 | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED |
| Tuesday, September 26, 2023 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Wednesday, December 6, 2023 | TEAS VOLUNTARY AMENDMENT RECEIVED |
| Wednesday, April 24, 2024 | ASSIGNED TO EXAMINER |
| Thursday, July 25, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, July 25, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, July 25, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Sunday, July 28, 2024 | FINAL REFUSAL WRITTEN |
| Sunday, July 28, 2024 | FINAL REFUSAL E-MAILED |
| Sunday, July 28, 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Thursday, April 25, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, April 25, 2024 | NON-FINAL ACTION E-MAILED |
| Thursday, April 25, 2024 | NON-FINAL ACTION WRITTEN |
